Head to Head Analysis: Hims & Hers Health (HIMS) & Its Rivals

Hims & Hers Health (NYSE:HIMS) is one of 60 public companies in the “MEDICAL INFO SYS” industry, but how does it weigh in compared to its competitors? We will compare Hims & Hers Health to related businesses based on the strength of its risk, institutional ownership, profitability, earnings, valuation, analyst recommendations and dividends.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for Hims & Hers Health and its competitors, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	3	8	2	0	1.92
Hims & Hers Health Competitors	252	742	1838	24	2.57

Hims & Hers Health currently has a consensus target price of $39.58, indicating a potential downside of 21.53%. As a group, “MEDICAL INFO SYS” companies have a potential upside of 32.02%. Given Hims & Hers Health’s competitors stronger consensus rating and higher possible upside, analysts clearly believe Hims & Hers Health has less favorable growth aspects than its competitors.

Institutional and Insider Ownership

63.5% of Hims & Hers Health shares are held by institutional investors. Comparatively, 42.3% of shares of all “MEDICAL INFO SYS” companies are held by institutional investors. 17.7% of Hims & Hers Health shares are held by company insiders. Comparatively, 18.0% of shares of all “MEDICAL INFO SYS” companies are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Volatility & Risk

Hims & Hers Health has a beta of 2.02, indicating that its stock price is 102% more volatile than the S&P 500. Comparatively, Hims & Hers Health’s competitors have a beta of -3.40, indicating that their average stock price is 440% less volatile than the S&P 500.

Profitability

This table compares Hims & Hers Health and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	9.24%	22.75%	15.51%
Hims & Hers Health Competitors	-194.24%	-97.38%	-20.44%

Valuation & Earnings

This table compares Hims & Hers Health and its competitors revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Hims & Hers Health	$1.48 billion	$126.04 million	73.10
Hims & Hers Health Competitors	$418.60 million	-$61.27 million	5.45

Hims & Hers Health has higher revenue and earnings than its competitors. Hims & Hers Health is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Summary

Hims & Hers Health beats its competitors on 8 of the 13 factors compared.

Hims & Hers Health Company Profile

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.